NCT00726895View on ClinicalTrials.gov

A Dose Proportionality Study of Quinine Sulfate Capsules Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

June 30, 2004

Study Completion Date

June 30, 2004

Conditions
Healthy
Interventions
DRUG

Quinine Sulfate Capsules 324 mg

1 x 324 mg capsule

DRUG

Quinine Sulfate Capsules 324 mg

2 x 324 mg capsules

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT00726895 - A Dose Proportionality Study of Quinine Sulfate Capsules Under Fasting Conditions | Biotech Hunter | Biotech Hunter